Stella surgical has gained the compliance not only of surgeons but also of public and private organisations because of its general order interest and the disruptive nature of its innovation.

Stella Surgical was selected by the French Agency of Biomedicine in the context of the 2019 request for proposals entitled “Research on transplantation”

In may 2019 we were awarded for the most relevant innovation in the field and the most disruptive innovation in the field during the international ILTS exhibition in Toronto.

Meanwhile, we were awarded by the audience during the AFC (French society of surgery) exhibition.